Synaptosomal Protein of 25 kDa (Snap25) Polymorphisms Associated with Glycemic Parameters in Type 2 Diabetes Patients

Journal of Diabetes Research
Nasser M Al-DaghriF R Guerini

Abstract

A possible role of Snap25 polymorphisms in type 2 diabetes mellitus (T2DM) was evaluated by analyzing three SNPs within intron 1 in a region known to affect the gene expression in vitro. Genomic DNA from 1019 Saudi individuals (489 confirmed T2DM and 530 controls) was genotyped for SNPs rs363039, rs363043, and rs363050 in Snap25 using the TaqMan Genotyping Assay. Significantly higher levels of fasting glucose and HbA1c were detected in T2DM patients carrying the rs363050 (AG/GG) genotypes compared to the (AA) genotype (f = 4.41, df = 1, and p = 0.03 and f = 5.31, df = 1, and p = 0.03, resp.). In these same patients, insulin levels were significantly decreased compared to the (AA) individuals (f = 7.29, df = 1, and p = 0.009). Significant associations were detected between rs363050 (AG/GG) genotypes and increasing fasting glucose levels (p = 0.01 and OR: 1.05), HbA1c levels (OR: 5.06 and p = 0.02), and lower insulinemia (p = 0.03 and OR: 0.95) in T2DM patients. The minor Snap25 rs363050 (G) allele, which results in a reduced expression of Snap25, is associated with altered glycemic parameters in T2DM possibly because of reduced functionality in the exocytotic machinery leading to suboptimal release of insulin.

References

Mar 1, 1995·The Journal of Cell Biology·K SadoulP A Halban
Jan 15, 2008·Journal of Psychiatric Research·Richard MusilBrigitta Bondy
Dec 24, 2008·Biochemical and Biophysical Research Communications·Guo-qing ZhuangYan He
Apr 24, 2009·Journal of Alzheimer's Disease : JAD·Daniel Kopf, Lutz Frölich
Jun 11, 2009·American Journal of Physiology. Endocrinology and Metabolism·Jenny VikmanLena Eliasson
Feb 15, 2012·Current Alzheimer Research·Suzanne M de la Monte

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
Genotyping

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.